Answers are grounded in this paper and cite their sources.
Arterial remodeling in response to reduced blood flow is an endothelium-dependent process likely mediated by an unidentified novel vasoactive substance.
Chronic decreases in arterial blood flow rates elicit arterial constriction followed by remodeling of the artery wall that entrenches a reduced internal diameter. This adaptive response may provide an important compensatory adaptation to physiological reductions in blood flow, but it may also exacerbate pathologic disorders that compromise tissue perfusion. A capacity to manipulate this response requires a knowledge of the mechanisms that control it. Our studies have shown that the response is endothelium-dependent, and that it is probably initiated by release of a vasoconstrictor. This finding suggests that endothelium-derived agonist(s) are involved. We assessed the potential role of prostanoids, endothelin, and a local vessel wall renin-angiotensin system. All of these assessments yielded negative results. It appears, therefore, that a novel vasoactive substance initiates the adaptive response of arteries to reduced blood flow.
No takes yet. Share an insight, caveat, or question.
Langille et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: